Free tool
Drug Trial Radar: Dermatology
Last checked: Nov 20, 2026Latest source record: Aug 6, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
1
Not yet recruiting, industry sponsors, Dermatology, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
1 trial
Showing 1 to 1, recently updated first.
- Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of WoundsNot yet recruiting
Abeona Therapeutics, IncIndustry
NCT07717736 · 100 participants (planned) · Start Nov 2026 · Primary completion Nov 2031
Drug: Non-conforming pz-cel surgical application to RDEB wounds; Pz-cel surgical application to DEB wounds · For: Epidermolysis Bullosa (EB); Recessive Dystrophic Epidermolysis Bullosa (RDEB); Dystrophic Epidermolysis Bullosa (DEB)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.